促血栓基因型对伴或不伴缺血性卒中患者静脉血栓栓塞风险的影响:特罗姆瑟研究
该基于人群的病例队列研究从特罗姆瑟研究三次调查中纳入664例静脉血栓栓塞(VTE)病例和1817名年龄加权亚队列,对5个单核苷酸多态性(SNP)进行基因分型。中位随访15.2年期间,192例发生卒中者中43例发生VTE。在卒中患者中,遗传风险评分每增加一个类别,总体VTE的相对风险增加50%(HR 1.5,95%CI 1.3-1.8),诱发性VTE的相对风险增加80%(HR 1.8,95%CI 1.5-2.1);携带≥5个风险等位基因的卒中患者VTE相对风险是无卒中且携带0-1个风险等位基因者的11.7倍(HR 11.7,95%CI 4.1-33.3)。
要点
- 卒中患者遗传风险评分每增加一个类别,总体VTE风险HR 1.5(95%CI 1.3-1.8)。
- 卒中患者遗传风险评分每增加一个类别,诱发性VTE风险HR 1.8(95%CI 1.5-2.1)。
- 卒中患者携带≥5个风险等位基因者较无卒中且0-1个等位基因者VTE风险HR 11.7(95%CI 4.1-33.3)。
核心结论
- 促血栓基因型增加卒中患者的VTE风险,且风险随风险等位基因数量增加而增加。
研究设计与样本
- 基于人群的病例队列研究,样本来自特罗姆瑟研究1994-2008年三次调查。
- 纳入664例 incident VTE 病例和1817名随机选取的年龄加权亚队列。
- 对ABO(rs8176719)、F5(rs6025)、F2(rs1799963)、FGG(rs2066865)和F11(rs2036914)五个单核苷酸多态性(SNP)进行基因分型。
- 采用Cox回归模型计算伴或不伴缺血性卒中者按单个SNP及风险等位基因类别(5-SNP评分;0-1、2、3-4和≥5)的VTE风险比(HR)。
主要发现
- 192例发生卒中,其中43例在中位15.2年随访期间发生VTE。
- 在卒中患者中,遗传风险评分每增加一个类别,总体VTE的相对风险增加50%(HR 1.5,95%CI 1.3-1.8)。
- 在卒中患者中,遗传风险评分每增加一个类别,诱发性VTE的相对风险增加80%(HR 1.8,95%CI 1.5-2.1)。
- 卒中患者携带≥5个风险等位基因者VTE相对风险是无卒中且携带0-1个风险等位基因者的11.7倍(HR 11.7,95%CI 4.1-33.3)。
- 单个SNP的风险等位基因可增强缺血性卒中带来的VTE风险升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials Prothrombotic genotypes may agument the risk of venous thromboembolism (VTE) after ischemic stroke. We studied this effect in a case-cohort study using a genetic risk score. In stroke patients, a one-category increase in the genetic risk score was associated with a 50% higher relative risk of VTE. The risk of VTE in stroke patients increased with an increasing number of risk alleles. SUMMARY: Background Patients with ischemic stroke have a transiently increased risk of subsequent venous thromboembolism (VTE). Prothrombotic genotypes may augment VTE risk under conditions of high thrombosis risk related to stroke. Aims To investigate the effect of prothrombotic genotypes in patients with ischemic stroke on the risk of VTE in a population-based case-cohort study. Methods Cases with incident VTE (n = 664) and a randomly selected age-weighted subcohort (n = 1817) were sampled from three surveys of the Tromsø Study (1994-2008). Participants were genotyped for ABO (rs8176719), F5 (rs6025), F2 (rs1799963), FGG (rs2066865) and F11 (rs2036914) single-nucleotide polymorphisms (SNPs). Cox regression models were used to calculate hazard ratios (HRs) for incident VTE according to individual SNPs and categories of risk alleles (5-SNP score; 0-1, 2, 3-4 and ≥ 5) in participants with and without ischemic stroke. Results There were 192 patients with incident stroke, of whom 43 developed VTE during a median of 15.2 years of follow-up. The risk alleles of individual SNPs augmented the elevated VTE risk brought about by ischemic stroke. In stroke patients, a one-category increase in the genetic risk score was associated with a 50% higher relative risk of overall VTE (HR 1.5, 95% confidence interval [CI] 1.3-1.8) and an 80% higher relative risk of provoked VTE (HR 1.8, 95% CI 1.5-2.1). Stroke patients with ≥ 5 risk alleles had a 12-fold (HR 11.7, 95% CI 4.1-33.3) higher relative risk of VTE than stroke-free participants with 0-1 risk alleles. Conclusions Prothrombotic genotypes increased the risk of VTE in stroke patients, and the risk increased with an increasing number of risk alleles.
引用
- Rinde LB, Morelli VM, Småbrekke B, et al. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study. J Thromb Haemost. 2019. PMID: 30773804. doi:10.1111/jth.14410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。